---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-023270"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2021-09-21T23:59:59+00:00"
generated_at: "2026-06-29T02:30:18.242324+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech CFO Ellen Lintal to retire effective March 31, 2022

## Summary
- Ellen Lintal informed Company on Sept 20, 2021 of her retirement as CFO.
- Retirement and contract non-renewal effective March 31, 2022.
- Lintal will stay post-retirement on a contractual basis to assist with SEC filings.
- CFO departure timed to allow completion of annual report on Form 10-K.
- CEO Thomas K. Equels signed the filing.

## SEC filing metadata
- accession: 0001493152-21-023270
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2021-09-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315221023270/0001493152-21-023270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315221023270/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-023270
- JSON: https://secwatch.observer/filing/0001493152-21-023270.json
- Plain text: https://secwatch.observer/filing/0001493152-21-023270.txt

## Key facts
- Executive change
  Ellen Lintal retired as Chief Financial Officer at AIM ImmunoTech Inc..
  - Action: retired
  - Role: Chief Financial Officer
  source text: On September 20, 2021, Ellen Lintal informed the Registrant that she intended to retire as Chief Financial Officer effective March 31, 2022 and, therefore, will not be renewing her contract.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315221023270/0001493152-21-023270-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.